Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/KS/Topeka
Updated November 2026 from ClinicalTrials.gov

Paid Clinical Trials in Topeka, KS

Studies commonly pay $75 to $4,500 per completed study

111 clinical trials are currently recruiting participants within 30 miles of Topeka. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

111studies recruiting
9+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Topeka right now

Top 25 of 111 recruiting studies, sorted by proximity — each links to its official registry page

Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program

Cigarette Smoking-Related Carcinoma Phase 3 Interventional 600 participants sought
Cotton O'Neil Cancer Center / Stormont Vail Health — Topeka, Kansas (1.3 mi) · Sponsor: Alliance for Clinical Trials in Oncology

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

Non-alcoholic Fatty Liver Disease Phase 3 Interventional 1,250 participants sought
GSK Investigational Site — Topeka, Kansas (1.3 mi) · Sponsor: GlaxoSmithKline

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Smoldering Plasma Cell Myeloma Phase 3 Interventional 288 participants sought
Cotton O'Neil Cancer Center / Stormont Vail Health — Topeka, Kansas (1.3 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma Phase 3 Interventional 1,295 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi) · Sponsor: Alliance for Clinical Trials in Oncology

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Overweight, Obesity Phase 2 Interventional 400 participants sought
Cotton O'Neil Diabetes & Endocrinology — Topeka, Kansas (1.3 mi) · Sponsor: Eli Lilly and Company

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
Lawrence Memorial Hospital — Lawrence, Kansas (25.1 mi) · Sponsor: National Cancer Institute (NCI)

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis Phase 3 Interventional 1,350 participants sought
89bio Clinical Study Site — Topeka, Kansas (1.3 mi) · Sponsor: Hoffmann-La Roche

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Phase 3 Interventional 2,400 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi) · Sponsor: SWOG Cancer Research Network

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Phase 2 Interventional 474 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi) · Sponsor: Alliance for Clinical Trials in Oncology

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Metabolic Dysfunction-Associated Steatotic Liver Disease Phase 3 Interventional 4,500 participants sought
Cotton O'Neil Digestive Health Center — Topeka, Kansas (1.3 mi) · Sponsor: Eli Lilly and Company

Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

Locally Advanced Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8 Phase 1, Phase 2 Interventional 92 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi) · Sponsor: National Cancer Institute (NCI)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Cotton O'Neil Cancer Center / Stormont Vail Health — Topeka, Kansas (1.3 mi) · Sponsor: SWOG Cancer Research Network

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma Phase 3 Interventional 382 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi) · Sponsor: Alliance for Clinical Trials in Oncology

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Phase 3 Interventional 1,524 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi) · Sponsor: Alliance for Clinical Trials in Oncology

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Acute Myeloid Leukemia Phase 2 Interventional 147 participants sought
Cotton O'Neil Cancer Center / Stormont Vail Health — Topeka, Kansas (1.3 mi) · Sponsor: National Cancer Institute (NCI)

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Phase 3 Interventional 1,978 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi) · Sponsor: National Cancer Institute (NCI)

A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis

Myasthenia Gravis Phase 2, Phase 3 Interventional 12 participants sought
University of Kansas Medical Center — Lawrence, Kansas (25.1 mi) · Sponsor: Janssen Research & Development, LLC

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Crohn's Disease Phase 3 Interventional 1,200 participants sought
Cotton O'Neil Digestive Health Center ( Site 5033) — Topeka, Kansas (1.3 mi) · Sponsor: Merck Sharp & Dohme LLC

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

Metabolic Dysfunction Associated Steatohepatitis (MASH), Liver Fibrosis Phase 3 Interventional 1,800 participants sought
Kansas Medical Clinic PA — Topeka, Kansas (1.3 mi) · Sponsor: Boehringer Ingelheim

Collection and Storage of Tissue and Blood Samples From Patients With Cancer

Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm N/A Observational 5,000 participants sought
Lawrence Memorial Hospital — Lawrence, Kansas (25.1 mi) · Sponsor: National Cancer Institute LAO

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Multiple conditions Phase 2 Interventional 314 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi) · Sponsor: National Cancer Institute (NCI)

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

NASH With Fibrosis, MASH With Fibrosis Phase 3 Interventional 1,650 participants sought
Akero Clinical Study Site — Topeka, Kansas (1.3 mi) · Sponsor: Akero Therapeutics, Inc

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD) Phase 3 Interventional 10,450 participants sought
Cotton O'Neil Clinical Research Center — Topeka, Kansas (1.3 mi) · Sponsor: Eli Lilly and Company
Actively enrolling

Studies you may be able to join near Topeka

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Topeka

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Cotton O’Neil Clinical Research Center

★ 5.0
and Basement, 823 SW Mulvane St 2nd Floor, Topeka, KS 66606
(785) 354-6000

KMC Research Center

★ 5.0
2200 SW 6th Ave, Topeka, KS 66606
(785) 295-0938
"Alyssa Nash was soooo supportive when answering my questions about a trial I’m thinking about taking part in. She made me feel so much more confident…"
— Natalie Bowman, 5★

Kansas Health Institute

★ 4.4
212 SW 8th Ave #300, Topeka, KS 66603
(785) 233-5443
"Health issues look at for my son"
— raymond foster, 4★

Stormont Vail Hospital - Topeka Campus

★ 2.6
1500 SW 10th Ave, Topeka, KS 66604
(785) 354-6000

Stormont Vail Health Cancer Center

★ 4.0
1414 SW 8th Ave, Topeka, KS 66606
(785) 354-5300
"Told me they didn't feel like doing further testing because it was "too expensive" still sick, still no answers, I wouldn't be surprised if this clin…"
— Malachite Hughes, 1★

Kansas Medical Clinic PA

★ 3.5
2200 SW 6th Ave, Topeka, KS 66606
"The Doctors and nurses were wonderful. The billing department is worthless. Heave BC BS of North Carolina. They it to Ks and refused to reprocess. H…"
— Trish Parre, 5★

Stormont Vail Health

★ 3.0
929 SW Mulvane St Fl 1, Topeka, KS 66606
(785) 354-6000
"Amanda at the front desk was very nice and helpful. Y’all are lucky to have her."
— Andy Smith, 5★

University of Kansas Medical Center Research Institute

★ 5.0
3901 Rainbow Blvd, Kansas City, KS 66160
(913) 588-1261
"The doctors are very nice and helpful."
— Everian Williams, 5★

Clinical Research Consultants

★ 4.6
3930 Washington St, Kansas City, MO 64111
(816) 756-1222
"They are the best especially my girl chandrika.she comes with great medical knowledge.i recommend everyone to Check them out."
— Edna Yancy, 5★

Clinical trials in Topeka: what's recruiting

The Topeka area currently has 111 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Topeka, the most active research areas are:

  • Cancer & Oncology14 studies
  • Liver & Kidney6 studies
  • Diabetes & Metabolism4 studies
  • Lungs & Breathing1 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Topeka, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Topeka

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Topeka participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Topeka pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Topeka safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
What is the difference between a research center and a hospital study in Topeka?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Topeka?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Topeka.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Topeka typically complete one or two studies per year.

Paid clinical trials near Topeka

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of KS

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts